1-2 of 2
Emily Lai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of a Phase 1/2 Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of Evofosfamide, a Hypoxia-Activated Prodrug, and Dexamethasone with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma

Jacob P. Laubach, MD, Noopur Raje, MD, Andrew J. Yee, MD, Philippe Armand, MD PhD, Robert L. Schlossman, MD, Jacalyn Rosenblatt, MD, Michael G. Martin, MD, Craig Reynolds, MD, Kenneth H. Shain, MD PhD, Ira Zackon, MD, Laura V. Stampleman, MD, Emily Lai, BS, Aaron M. Caola, BS, Joseph M. Cappuccio, BS, Bradley Rivotto, BS, Kaitlen Reyes, DNP, Alexandra Savell, BS, Patrick Henrick, BS, Tillman Pearce, MD, Damian Handisides, Stew Kroll, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2016) 128 (22): 2122.
https://doi.org/10.1182/blood.V128.22.2122.2122
Published: 2016
Journal Articles

Final Results of the Phase I/II Study of Chemosensitization Using the CXCR4 Inhibitor Plerixafor in Combination with Bortezomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma

Irene M. Ghobrial, MD, Kenneth H. Shain, MD, Jacob Laubach, MD, Patrick Henrick, James Vredenburg, MD, Pamela Crilley, MD, Michael Constantine, MD, Caroline Block, MD, Frank G. Basile, MD, Joseph Cappuccio, Abdel Kareem Azab, BPharm, PhD, Emily Lai, Aaron Caola, Ranjit Banwait, Alexandra Savell, Nikhil C. Munshi, MD, Claudia E. Paba-Prada, MD, Robert L. Schlossman, MD, Stacey Chuma, BSN, Kimberly Noonan, NP, Kenneth C. Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2015) 126 (23): 4256.
https://doi.org/10.1182/blood.V126.23.4256.4256
Published: 2015